» Articles » PMID: 8289837

Role of the Histone Amino Termini in Facilitated Binding of a Transcription Factor, GAL4-AH, to Nucleosome Cores

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1994 Feb 1
PMID 8289837
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Facilitated, "cooperative" binding of GAL4-AH to nucleosomal DNA occurred in response to inhibition from the core histone amino termini. The binding of GAL4-AH (which contains the DNA-binding and dimerization domains of GAL4) to nucleosome cores containing multiple binding sites initiated at the end of a nucleosome core and proceeded in a cooperative manner until all sites were occupied. However, following tryptic removal of the core histone amino termini, GAL4-AH binding appeared to be noncooperative, similar to binding naked DNA. Binding of GAL4-AH to nucleosomes bearing a single GAL4 site at different positions indicated that inhibition of GAL4 binding was largely mediated by the histone amino termini and primarily occurred at sites well within the core and not near the end. When the histone amino termini were intact, binding of GAL4-AH to sites near the center of a nucleosome core was greatly enhanced by the presence of additional GAL4 dimers bound to more-accessible positions. These data illustrate that the binding of a factor to more-accessible sites, near the end of a nucleosome, allows facilitated binding of additional factors to the center of the nucleosome, thereby overcoming repression from the core histone amino termini. This mechanism may contribute to the binding of multiple factors to complex promoter and enhancer elements in cellular chromatin.

Citing Articles

A test of the pioneer factor hypothesis using ectopic liver gene activation.

Hansen J, Loell K, Cohen B Elife. 2022; 11.

PMID: 34984978 PMC: 8849321. DOI: 10.7554/eLife.73358.


Chromatin-modifying drugs and metabolites in cell fate control.

Yao Z, Chen Y, Cao W, Shyh-Chang N Cell Prolif. 2020; 53(11):e12898.

PMID: 32979011 PMC: 7653270. DOI: 10.1111/cpr.12898.


Pioneer factors and their in vitro identification methods.

Yu X, Buck M Mol Genet Genomics. 2020; 295(4):825-835.

PMID: 32296927 PMC: 7405852. DOI: 10.1007/s00438-020-01675-9.


Defining TP53 pioneering capabilities with competitive nucleosome binding assays.

Yu X, Buck M Genome Res. 2018; 29(1):107-115.

PMID: 30409772 PMC: 6314159. DOI: 10.1101/gr.234104.117.


Human OGG1 activity in nucleosomes is facilitated by transient unwrapping of DNA and is influenced by the local histone environment.

Bilotti K, Kennedy E, Li C, Delaney S DNA Repair (Amst). 2017; 59:1-8.

PMID: 28892740 PMC: 5643252. DOI: 10.1016/j.dnarep.2017.08.010.


References
1.
Pina B, Bruggemeier U, Beato M . Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter. Cell. 1990; 60(5):719-31. DOI: 10.1016/0092-8674(90)90087-u. View

2.
Lee D, HAYES J, Pruss D, Wolffe A . A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell. 1993; 72(1):73-84. DOI: 10.1016/0092-8674(93)90051-q. View

3.
Workman J, Roeder R, Kingston R . An upstream transcription factor, USF (MLTF), facilitates the formation of preinitiation complexes during in vitro chromatin assembly. EMBO J. 1990; 9(4):1299-308. PMC: 551808. DOI: 10.1002/j.1460-2075.1990.tb08239.x. View

4.
Carey M, Lin Y, Green M, Ptashne M . A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature. 1990; 345(6273):361-4. DOI: 10.1038/345361a0. View

5.
Grunstein M . Histone function in transcription. Annu Rev Cell Biol. 1990; 6:643-78. DOI: 10.1146/annurev.cb.06.110190.003235. View